Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Constantinou

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Leukemia & Lymphoma|February 1, 1995
Anaplastic myelomaK Zervas, N Constantinou, M Karakantza, et al.
QJM : Monthly Journal of the Association of Physicians|February 22, 2013
Long-term outcome of primary endocrine non-Hodgkin lymphomas: does the site make the difference?E Hatjiharissi, M D Diamantidis, M Papaioannou, et al.
Leukemia Research|March 3, 2009
Extramedullary (EMP) relapse in unusual locations in multiple myeloma: Is there an association with precedent thalidomide administration and a correlation of special biological features with treatment and outcome?E Katodritou, V Gastari, E Verrou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2010
Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network studyC Onal, Y X Li, R C Miller, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Leukemia & Lymphoma|February 1, 1995
Anaplastic myelomaK Zervas, N Constantinou, M Karakantza, et al.
QJM : Monthly Journal of the Association of Physicians|February 22, 2013
Long-term outcome of primary endocrine non-Hodgkin lymphomas: does the site make the difference?E Hatjiharissi, M D Diamantidis, M Papaioannou, et al.
Leukemia Research|March 3, 2009
Extramedullary (EMP) relapse in unusual locations in multiple myeloma: Is there an association with precedent thalidomide administration and a correlation of special biological features with treatment and outcome?E Katodritou, V Gastari, E Verrou, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 2010
Treatment results and prognostic factors in primary thyroid lymphoma patients: a rare cancer network studyC Onal, Y X Li, R C Miller, et al.
Pageof 1